Suppr超能文献

外周动脉手术中使用达迪克生物移植物的远期结果。

Late results with Dardik-biograft in peripheral arterial surgery.

作者信息

Raithel D, Schweiger H, Gentsch H H

出版信息

J Cardiovasc Surg (Torino). 1984 May-Jun;25(3):222-4.

PMID:6736116
Abstract

A total of 117 vascular reconstructions below the inguinal ligament were performed using Dardik's human umbilical vein. The indication for surgery was limb salvage in 91.5%. In 61.5% a previous reconstruction had failed. The distal anastomosis was done with the popliteal artery above the knee in 9 cases, below the knee in 41, and with a tibial or the peroneal artery in 60 cases. The umbilical vein was combined with a prosthesis or the autologous saphenous vein in 20 cases. The cumulative patency rates of all reconstructions were 59.6% after 3, and 46.7% after 6 years. Crural reconstructions had a cumulative patency rate of 52% 3 years after surgery. The main factors influencing patency were the preoperative grade of ischemia, the site of the distal anastomosis and the angiographic run-off. It is concluded that the human umbilical vein is the graft material of choice in long length revascularization whenever the saphenous vein is not available.

摘要

使用达迪克人脐静脉对117例腹股沟韧带以下的血管进行了重建。手术指征为挽救肢体,占91.5%。61.5%的患者先前的重建手术失败。9例患者的远端吻合在膝上腘动脉进行,41例在膝下进行,60例与胫动脉或腓动脉进行。20例患者的脐静脉与假体或自体大隐静脉联合使用。所有重建手术3年后的累积通畅率为59.6%,6年后为46.7%。小腿重建术后3年的累积通畅率为52%。影响通畅的主要因素是术前缺血程度、远端吻合部位和血管造影的流出情况。结论是,在无法获得大隐静脉时,人脐静脉是长段血管重建的首选移植材料。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验